Fidelity Investments
RKDA icon

Fidelity Investments’s Arcadia Biosciences RKDA Stock Holding History

Fidelity Investments’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8
Closed -$60 – 5563
2023
Q1 		$60 Buy
+8
New +$85 ﹤0.01% 4950
2022
Q4 		– Sell
-250
Closed -$5K – 5550
2022
Q3 		$5K Buy
+250
New +$8.53K ﹤0.01% 4329

Other funds holding RKDA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
OLVIG
Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM

Fidelity Investments's RKDA Position: Q2 2023 in Review

Fidelity Investments sold out of Arcadia Biosciences (RKDA) in Q2 2023, closing a stake of 8 shares — an estimated $60 sold.

Fidelity Investments first reported a position in RKDA in Q3 2022 and held it in 2 quarters. The position peaked at $5K in Q3 2022. 13 funds tracked by Wall St. Rank hold RKDA as of Q2 2023.

  • Fidelity Investments reported no remaining Arcadia Biosciences position as of Q2 2023 after selling out during the quarter.
  • Fidelity Investments sold 8 Arcadia Biosciences shares in Q2 2023, an estimated $60.
  • Fidelity Investments first reported a position in Arcadia Biosciences in Q3 2022 and held it in 2 quarters.
  • Fidelity Investments's Arcadia Biosciences position peaked at $5K in Q3 2022.
  • 13 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2023.

Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.